Ro5

The AI engine Fit Assessment

Beta

Ro5 leverages machine learning to enhance drug discovery, identify patterns, and expand therapeutic options, including drug repurposing efforts for COVID-19.

Blurb

Biotechnology

HQ Location

London (United Kingdom)

Founded

2018

Employees

11 - 50

Total funding raised

Not available

Funding Status

Acquired by Juvenescence, June 2025
Subspaces
  • Drug Repurposing

Accessible AI for all drug discovery researchers.



At Ro5, we provide the benefits of AI and digital transformation through a software platform that empowers our clients to focus on what they’re best at - drug discovery.



Ro5 makes AI accessible to the industry by providing the expertise, infrastructure, software, models, and data necessary for digital transformation. Our software products are developed for real-world challenges, solving the unique problems faced by our clients that focus on R&D. Our solutions augment researcher’s workflows, enable data-driven decisions, and accelerate research.



Ro5 has 5 years of experience providing services and software for pharmaceutical companies and CROs in projects spanning the entire drug discovery and development pipeline. Ro5 has a growing portfolio of scientific publications with 3 papers and 13 awarded patents.



Contact us to learn more about how Ro5’s platforms and digital transformation could help achieve your and your organization’s research goals.